首页 > 最新文献

Cytopathology最新文献

英文 中文
Commentary on ‘Development and validation of a minimally invasive protocol for assessing oxidative stress markers in exfoliated oral cells’ 关于 "评估脱落口腔细胞中氧化应激标记物的微创方案的开发与验证 "的评论。
IF 1.2 4区 医学 Q4 CELL BIOLOGY Pub Date : 2024-08-02 DOI: 10.1111/cyt.13430
Divyanshu Mohan Arya, Shruti Gupta, Gargi Kapatia, Niraj Kumari

The assessment of reactive oxygen species (ROS) offers immense prospects for the diagnosis of chronic diseases. A protocol to assess redox imbalance in exfoliated cells can prove beneficial in our understanding of the role of ROS in the diagnosis of these diseases. Further studies on the development of such protocols are needed.

活性氧(ROS)的评估为诊断慢性疾病提供了广阔的前景。评估脱落细胞中氧化还原失衡的方案有助于我们了解 ROS 在诊断这些疾病中的作用。我们需要进一步研究此类方案的开发。
{"title":"Commentary on ‘Development and validation of a minimally invasive protocol for assessing oxidative stress markers in exfoliated oral cells’","authors":"Divyanshu Mohan Arya,&nbsp;Shruti Gupta,&nbsp;Gargi Kapatia,&nbsp;Niraj Kumari","doi":"10.1111/cyt.13430","DOIUrl":"10.1111/cyt.13430","url":null,"abstract":"<p>The assessment of reactive oxygen species (ROS) offers immense prospects for the diagnosis of chronic diseases. A protocol to assess redox imbalance in exfoliated cells can prove beneficial in our understanding of the role of ROS in the diagnosis of these diseases. Further studies on the development of such protocols are needed.</p>","PeriodicalId":55187,"journal":{"name":"Cytopathology","volume":"35 6","pages":"792-793"},"PeriodicalIF":1.2,"publicationDate":"2024-08-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876807","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Application of the international system for reporting serous fluid cytopathology on pleural effusion cytology with paired pleural biopsy: A new insight and novel approach on risk of malignancy 将国际浆液细胞病理学报告系统应用于胸腔积液细胞学配对胸膜活检:关于恶性肿瘤风险的新见解和新方法。
IF 1.2 4区 医学 Q4 CELL BIOLOGY Pub Date : 2024-08-01 DOI: 10.1111/cyt.13423
Zahra Maleki, Ashleigh J. Graham, Robert Jones, Ricardo Pastorello, Paul Morris, Alessandra C. Schmitt, Erika F. Rodriguez

Introduction

The risk of malignancy (ROM) remains an area of interest for further evaluation in reporting systems including in International System for reporting serous fluid cytopathology (TIS), which is a standardized system for reporting effusion cytology. Herein, we report our findings in further investigation of ROM in TIS by studying on paired pleural effusion specimens and corresponding pleural biopsies with emphasis on negative for malignancy, and atypia of undetermined significance categories.

Materials and Methods

The  Johns Hopkins Hospital pathology database was retrospectively searched for patients with a pleural biopsy (PBX) and a paired pleural effusion (PF) cytology specimens over a 4-year period. We employed the TIS categories. The following statistical parameters were evaluated: sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and ROM.

Results

A total of 223 patient cases were included. Effusions TIS reclassification and ROM were as follows: 1.8% non-diagnostic (ROM 75%), 75.8% negative for malignancy (ROM 23%), 4.9% atypical cells of undetermined significance (ROM 45%), 2.2% suspicious for malignancy (ROM 80%), and 15.2% malignant (ROM 100%). Overall accuracy, sensitivity, specificity, PPV and NPV were calculated and were 79.4%, 45%, 97.7%, 91.2% and 77%, respectively. Among, discordant cases diagnosed negative for malignancy on PF and positive for malignancy on PBX, there were significant number of lymphomas, mesotheliomas, and sarcomas. Lung cancer was the most common carcinoma; however, rare types of carcinomas were noted. Cells blocks and immunohistochemistry (IHC) studies were utilized to confirm either malignant conditions or rule out malignancy in both cell blocks and histology biopsies.

Conclusion

This study demonstrates the high specificity and ROM for ‘malignant’ and ‘suspicious for malignancy’ categories in the TIS reporting system and highlights the modest negative predictive value for the ‘negative for malignancy’ category. Although Tissue biopsies are usually considered as ‘gold standard’, any definitive diagnosis of malignancy of body fluid should be considered positive for malignancy in further clinical decision-making.

导言:恶性肿瘤风险(ROM)仍是报告系统中需要进一步评估的领域,包括国际浆液细胞病理学报告系统(TIS),该系统是报告渗出液细胞学的标准化系统。在此,我们通过研究成对的胸腔积液标本和相应的胸膜活检,重点研究恶性肿瘤阴性和意义未定的不典型性类别,报告我们在进一步研究 TIS 中 ROM 的发现:我们在约翰霍普金斯医院病理数据库中回顾性检索了4年内胸膜活检(PBX)和配对胸腔积液(PF)细胞学标本的患者。我们采用了 TIS 分类。对以下统计参数进行了评估:敏感性、特异性、阳性预测值(PPV)、阴性预测值(NPV)和 ROM:结果:共纳入 223 例患者。结果:共纳入 223 例患者:1.8%为非诊断性(ROM 75%),75.8%为恶性阴性(ROM 23%),4.9%为意义不明的非典型细胞(ROM 45%),2.2%为恶性可疑细胞(ROM 80%),15.2%为恶性(ROM 100%)。计算得出的总体准确率、敏感性、特异性、PPV 和 NPV 分别为 79.4%、45%、97.7%、91.2% 和 77%。在 PF 诊断为恶性肿瘤阴性而 PBX 诊断为恶性肿瘤阳性的不一致病例中,有大量淋巴瘤、间皮瘤和肉瘤。肺癌是最常见的癌症,但也有罕见类型的癌症。利用细胞块和免疫组织化学(IHC)研究来确认细胞块和组织学活检中的恶性病变或排除恶性病变:本研究表明,在 TIS 报告系统中,"恶性 "和 "恶性可疑 "类别的特异性和 ROM 都很高,并强调了 "恶性阴性 "类别的阴性预测值并不高。虽然组织活检通常被视为 "金标准",但在进一步的临床决策中,任何体液恶性肿瘤的明确诊断都应被视为恶性肿瘤阳性。
{"title":"Application of the international system for reporting serous fluid cytopathology on pleural effusion cytology with paired pleural biopsy: A new insight and novel approach on risk of malignancy","authors":"Zahra Maleki,&nbsp;Ashleigh J. Graham,&nbsp;Robert Jones,&nbsp;Ricardo Pastorello,&nbsp;Paul Morris,&nbsp;Alessandra C. Schmitt,&nbsp;Erika F. Rodriguez","doi":"10.1111/cyt.13423","DOIUrl":"10.1111/cyt.13423","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>The risk of malignancy (ROM) remains an area of interest for further evaluation in reporting systems including in International System for reporting serous fluid cytopathology (TIS), which is a standardized system for reporting effusion cytology. Herein, we report our findings in further investigation of ROM in TIS by studying on paired pleural effusion specimens and corresponding pleural biopsies with emphasis on negative for malignancy, and atypia of undetermined significance categories.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>The  Johns Hopkins Hospital pathology database was retrospectively searched for patients with a pleural biopsy (PBX) and a paired pleural effusion (PF) cytology specimens over a 4-year period. We employed the TIS categories. The following statistical parameters were evaluated: sensitivity, specificity, positive predictive value (PPV), negative predictive value (NPV), and ROM.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 223 patient cases were included. Effusions TIS reclassification and ROM were as follows: 1.8% non-diagnostic (ROM 75%), 75.8% negative for malignancy (ROM 23%), 4.9% atypical cells of undetermined significance (ROM 45%), 2.2% suspicious for malignancy (ROM 80%), and 15.2% malignant (ROM 100%). Overall accuracy, sensitivity, specificity, PPV and NPV were calculated and were 79.4%, 45%, 97.7%, 91.2% and 77%, respectively. Among, discordant cases diagnosed negative for malignancy on PF and positive for malignancy on PBX, there were significant number of lymphomas, mesotheliomas, and sarcomas. Lung cancer was the most common carcinoma; however, rare types of carcinomas were noted. Cells blocks and immunohistochemistry (IHC) studies were utilized to confirm either malignant conditions or rule out malignancy in both cell blocks and histology biopsies.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>This study demonstrates the high specificity and ROM for ‘malignant’ and ‘suspicious for malignancy’ categories in the TIS reporting system and highlights the modest negative predictive value for the ‘negative for malignancy’ category. Although Tissue biopsies are usually considered as ‘gold standard’, any definitive diagnosis of malignancy of body fluid should be considered positive for malignancy in further clinical decision-making.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55187,"journal":{"name":"Cytopathology","volume":"35 6","pages":"695-705"},"PeriodicalIF":1.2,"publicationDate":"2024-08-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141876806","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transient ‘NeoBRAF wild type’ state in a patient with BRAFV600E mutant metastatic colorectal cancer 一名 BRAFV600E 突变转移性结直肠癌患者的短暂 "NeoBRAF 野生型 "状态。
IF 1.2 4区 医学 Q4 CELL BIOLOGY Pub Date : 2024-07-31 DOI: 10.1111/cyt.13429
Claudia Cardone, Sergio Facchini, Alfonso de Stefano, Anna Maria Rachiglio, Antonio Avallone

We report the case of a patient with a BRAFV600E mutant mCRC, with evidence of acquired ‘NeoBRAF wild-type’ (wt) state. The patient, longitudinally assessed by liquid biopsy, obtained a remarkable clinical outcome with a multimodal approach including surgery, systemic treatment and targeted therapy.

In patients with newly diagnosed RAS and BRAFV600E mutant mCRC, longitudinal assessment with liquid biopsy is not routinely used in clinical practice. We report the case of a patient with a BRAFV600E mutant mCRC, with evidence of acquired ‘neoBRAF wild-type’ (wt) state. The patient obtained a remarkable clinical outcome and has been longitudinally assessed by liquid biopsy.

我们报告了一例 BRAFV600E 突变 mCRC 患者的病例,有证据表明患者获得了 "NeoBRAF 野生型"(wt)状态。该患者通过液体活检进行了纵向评估,并通过手术、全身治疗和靶向治疗等多模式方法获得了显著的临床疗效。对于新诊断的 RAS 和 BRAFV600E 突变 mCRC 患者,临床实践中并未常规使用液体活检进行纵向评估。我们报告了一例 BRAFV600E 突变 mCRC 患者的病例,有证据表明患者获得了 "新 BRAF 野生型"(wt)状态。该患者获得了显著的临床疗效,并通过液体活检进行了纵向评估。
{"title":"Transient ‘NeoBRAF wild type’ state in a patient with BRAFV600E mutant metastatic colorectal cancer","authors":"Claudia Cardone,&nbsp;Sergio Facchini,&nbsp;Alfonso de Stefano,&nbsp;Anna Maria Rachiglio,&nbsp;Antonio Avallone","doi":"10.1111/cyt.13429","DOIUrl":"10.1111/cyt.13429","url":null,"abstract":"<p>We report the case of a patient with a BRAF<sup>V600E</sup> mutant mCRC, with evidence of acquired ‘NeoBRAF wild-type’ (wt) state. The patient, longitudinally assessed by liquid biopsy, obtained a remarkable clinical outcome with a multimodal approach including surgery, systemic treatment and targeted therapy.\u0000 <figure>\u0000 <div><picture>\u0000 <source></source></picture><p></p>\u0000 </div>\u0000 </figure></p><p>In patients with newly diagnosed <i>RAS</i> and <i>BRAF</i><sup><i>V600E</i></sup> mutant mCRC, longitudinal assessment with liquid biopsy is not routinely used in clinical practice. We report the case of a patient with a <i>BRAF</i><sup><i>V600E</i></sup> mutant mCRC, with evidence of acquired ‘neo<i>BRAF</i> wild-type’ (wt) state. The patient obtained a remarkable clinical outcome and has been longitudinally assessed by liquid biopsy.</p>","PeriodicalId":55187,"journal":{"name":"Cytopathology","volume":"35 6","pages":"671-673"},"PeriodicalIF":1.2,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cyt.13429","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141861734","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Pericardial effusion: Unusual immunohistochemical expression 心包积液:不寻常的免疫组化表达。
IF 1.2 4区 医学 Q4 CELL BIOLOGY Pub Date : 2024-07-31 DOI: 10.1111/cyt.13425
Ying Liu, Yan Zhang, Rui Wang, Xiao Guo, Yang Ma, Yun Du

Endometrial Gastric-type Carcinoma is a rare disease, especially in cytology. A 65-year-old woman was admitted to the hospital due to intermittent chest tightness with dyspnoea. The chest CT showed a soft tissue shadow of the left lung with bronchial occlusion and pericardial effusion. What was her diagnosis?

子宫内膜胃型癌是一种罕见疾病,尤其是在细胞学方面。一名 65 岁的妇女因间歇性胸闷伴呼吸困难入院。胸部 CT 显示左肺软组织影,伴有支气管闭塞和心包积液。她的诊断结果是什么?
{"title":"Pericardial effusion: Unusual immunohistochemical expression","authors":"Ying Liu,&nbsp;Yan Zhang,&nbsp;Rui Wang,&nbsp;Xiao Guo,&nbsp;Yang Ma,&nbsp;Yun Du","doi":"10.1111/cyt.13425","DOIUrl":"10.1111/cyt.13425","url":null,"abstract":"<p>Endometrial Gastric-type Carcinoma is a rare disease, especially in cytology. A 65-year-old woman was admitted to the hospital due to intermittent chest tightness with dyspnoea. The chest CT showed a soft tissue shadow of the left lung with bronchial occlusion and pericardial effusion. What was her diagnosis?</p>","PeriodicalId":55187,"journal":{"name":"Cytopathology","volume":"35 6","pages":"786-788"},"PeriodicalIF":1.2,"publicationDate":"2024-07-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141857172","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The Bethesda System for Reporting Thyroid Cytopathology in the African American population: A tertiary centre experience 非裔美国人甲状腺细胞病理学报告贝塞斯达系统:一个三级中心的经验。
IF 1.2 4区 医学 Q4 CELL BIOLOGY Pub Date : 2024-07-29 DOI: 10.1111/cyt.13426
Carla Saoud, Gabrielle E. Bailey, Ashleigh J. Graham, Zahra Maleki

Background

The reported risk of malignancies (ROM) remains controversial for fine needle aspiration (FNA) of thyroid nodules in the African American (AA) population. Herein, the ROM along with frequency was assessed for each of the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) diagnostic categories.

Materials and Methods

The electronic pathology archive of a large academic hospital was retrospectively searched for cytopathology reports of thyroid nodules in AA patients (2010–2019) and Non-African American (NAA) control cases. The patients' demographic, thyroid nodule characteristics, FNA results using TBSRTC and surgical diagnoses were recorded, whenever available.

Results

Three hundred ninety-one cases were identified, 317 females (81.1%) and 74 males (18.9%) with median age 50.0 (SD = 14.4). The mean size of the nodules was 2.1 cm (SD = 1.4). The Bethesda categories were: 5.4% (I), 35.0% (II), 35.3% (III), 7.7% (IV), 3.3% (V) and 13.3% (VI). The overall ROM of thyroid nodules was 43.8% (89/203) on surgical follow-up (203/391). The ROM in each Bethesda categories were: 33.3% (I), 11.6% (II), 35.2% (III), 15.8% (IV), 83.3% (V) and 100% (VI) on surgical follow-up. The frequency of thyroid nodules was higher in AA females; however, the ROM was higher in AA males (48.3%) compared with AA females (41.2%).

Conclusion

The ROM in Categories I, II and III was higher than those reported in the TBSRTC while being similar in Categories IV, V and VI. The overall risk of thyroid malignancy in our AA patient population was higher than those in the literature. The overall ROM of thyroid nodules in AA males was higher than of AA females.

背景:关于非裔美国人(AA)甲状腺结节细针穿刺(FNA)的恶性肿瘤风险(ROM)仍存在争议。在此,我们评估了贝塞斯达甲状腺细胞病理学报告系统(TBSRTC)各诊断类别的恶性肿瘤风险及发生频率:对一家大型学术医院的电子病理档案进行了回顾性检索,以获得AA患者(2010-2019年)和非非洲裔美国人(NAA)对照病例的甲状腺结节细胞病理学报告。只要有患者的人口统计学特征、甲状腺结节特征、使用TBSRTC的FNA结果和手术诊断结果,就会记录在案:共发现 391 例患者,其中女性 317 例(81.1%),男性 74 例(18.9%),中位年龄为 50.0 岁(SD = 14.4)。结节的平均大小为 2.1 厘米(SD = 1.4)。贝塞斯达分类为5.4%(Ⅰ)、35.0%(Ⅱ)、35.3%(Ⅲ)、7.7%(Ⅳ)、3.3%(Ⅴ)和13.3%(Ⅵ)。在手术随访(203/391)中,甲状腺结节的总ROM为43.8%(89/203)。贝塞斯达分级的ROM分别为手术随访时,各Bethesda分类的ROM分别为:33.3%(I)、11.6%(II)、35.2%(III)、15.8%(IV)、83.3%(V)和100%(VI)。甲状腺结节的发生率在AA女性中较高,但AA男性的ROM(48.3%)高于AA女性(41.2%):结论:I、II和III类甲状腺结节的ROM高于TBSRTC报告的ROM,而IV、V和VI类甲状腺结节的ROM与TBSRTC报告的ROM相似。在我们的 AA 患者群体中,甲状腺恶性肿瘤的总体风险高于文献报道。AA男性甲状腺结节的总ROM高于AA女性。
{"title":"The Bethesda System for Reporting Thyroid Cytopathology in the African American population: A tertiary centre experience","authors":"Carla Saoud,&nbsp;Gabrielle E. Bailey,&nbsp;Ashleigh J. Graham,&nbsp;Zahra Maleki","doi":"10.1111/cyt.13426","DOIUrl":"10.1111/cyt.13426","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The reported risk of malignancies (ROM) remains controversial for fine needle aspiration (FNA) of thyroid nodules in the African American (AA) population. Herein, the ROM along with frequency was assessed for each of the Bethesda System for Reporting Thyroid Cytopathology (TBSRTC) diagnostic categories.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>The electronic pathology archive of a large academic hospital was retrospectively searched for cytopathology reports of thyroid nodules in AA patients (2010–2019) and Non-African American (NAA) control cases. The patients' demographic, thyroid nodule characteristics, FNA results using TBSRTC and surgical diagnoses were recorded, whenever available.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Three hundred ninety-one cases were identified, 317 females (81.1%) and 74 males (18.9%) with median age 50.0 (SD = 14.4). The mean size of the nodules was 2.1 cm (SD = 1.4). The Bethesda categories were: 5.4% (I), 35.0% (II), 35.3% (III), 7.7% (IV), 3.3% (V) and 13.3% (VI). The overall ROM of thyroid nodules was 43.8% (89/203) on surgical follow-up (203/391). The ROM in each Bethesda categories were: 33.3% (I), 11.6% (II), 35.2% (III), 15.8% (IV), 83.3% (V) and 100% (VI) on surgical follow-up. The frequency of thyroid nodules was higher in AA females; however, the ROM was higher in AA males (48.3%) compared with AA females (41.2%).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The ROM in Categories I, II and III was higher than those reported in the TBSRTC while being similar in Categories IV, V and VI. The overall risk of thyroid malignancy in our AA patient population was higher than those in the literature. The overall ROM of thyroid nodules in AA males was higher than of AA females.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55187,"journal":{"name":"Cytopathology","volume":"35 6","pages":"715-723"},"PeriodicalIF":1.2,"publicationDate":"2024-07-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141794163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are we ready to bridge classification systems? A comprehensive review of different reporting systems in thyroid cytology 我们准备好连接分类系统了吗?全面回顾甲状腺细胞学的不同报告系统。
IF 1.2 4区 医学 Q4 CELL BIOLOGY Pub Date : 2024-07-26 DOI: 10.1111/cyt.13411
Esther Diana Rossi, Liron Pantanowitz

The evaluation of thyroid lesions is common in the daily practice of cytology. While the majority of thyroid nodules are benign, in recent decades, there has been increased detection of small and well-differentiated thyroid cancers. Combining ultrasound evaluation with fine-needle aspiration cytology (FNAC) is extremely useful in the management of thyroid nodules. Furthermore, the adoption of specific terminology, introduced by different thyroid reporting systems, has helped effectively communicate thyroid FNAC diagnoses in a clear and understandable way. In 1996, the Papanicolaou Society thyroid cytological classification was introduced. This was followed in 2005 by the first Japanese and then in 2007 by the Bethesda System for Reporting Thyroid Cytopathology, which subsequently underwent two revisions. Other international thyroid terminology classifications include the British, Italian, Australasian and other Japanese cytology systems. This review covers similarities and differences among these cytology classification systems and highlights key points that unify these varied approaches to reporting thyroid FNAC diagnoses.

对甲状腺病变进行评估是细胞学日常工作中的常见内容。虽然大多数甲状腺结节是良性的,但近几十年来,发现的分化良好的小甲状腺癌越来越多。将超声评估与细针穿刺细胞学检查(FNAC)相结合,对甲状腺结节的治疗非常有用。此外,不同的甲状腺报告系统所采用的特定术语也有助于以清晰易懂的方式有效传达甲状腺细针穿刺细胞学诊断结果。1996 年,巴氏学会推出了甲状腺细胞学分类。2005 年,日本首次采用了这一系统,2007 年,贝塞斯达甲状腺细胞病理学报告系统(Bethesda System for Reporting Thyroid Cytopathology)采用了这一系统,随后又进行了两次修订。其他国际甲状腺术语分类包括英国、意大利、澳大利亚和其他日本细胞学系统。本综述涵盖了这些细胞学分类系统之间的异同,并强调了统一这些不同甲状腺 FNAC 诊断报告方法的要点。
{"title":"Are we ready to bridge classification systems? A comprehensive review of different reporting systems in thyroid cytology","authors":"Esther Diana Rossi,&nbsp;Liron Pantanowitz","doi":"10.1111/cyt.13411","DOIUrl":"10.1111/cyt.13411","url":null,"abstract":"<p>The evaluation of thyroid lesions is common in the daily practice of cytology. While the majority of thyroid nodules are benign, in recent decades, there has been increased detection of small and well-differentiated thyroid cancers. Combining ultrasound evaluation with fine-needle aspiration cytology (FNAC) is extremely useful in the management of thyroid nodules. Furthermore, the adoption of specific terminology, introduced by different thyroid reporting systems, has helped effectively communicate thyroid FNAC diagnoses in a clear and understandable way. In 1996, the Papanicolaou Society thyroid cytological classification was introduced. This was followed in 2005 by the first Japanese and then in 2007 by the Bethesda System for Reporting Thyroid Cytopathology, which subsequently underwent two revisions. Other international thyroid terminology classifications include the British, Italian, Australasian and other Japanese cytology systems. This review covers similarities and differences among these cytology classification systems and highlights key points that unify these varied approaches to reporting thyroid FNAC diagnoses.</p>","PeriodicalId":55187,"journal":{"name":"Cytopathology","volume":"35 6","pages":"674-681"},"PeriodicalIF":1.2,"publicationDate":"2024-07-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cyt.13411","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141762775","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Practical issues related to immunocytochemistry on cytological smears: Tips and recommendations 与细胞涂片免疫细胞化学有关的实际问题:提示和建议。
IF 1.2 4区 医学 Q4 CELL BIOLOGY Pub Date : 2024-07-16 DOI: 10.1111/cyt.13419
Maria D. Lozano, Allan Argueta, Ramón Robledano, Jaione García, Vanessa Ocon, Nerea Gómez, Nassira Fernandez

Objective

Immunocytochemistry (ICC) is essential for enhancing diagnostic accuracy and identifying markers for diagnosis, prognosis and targeted therapies. While cell blocks (CBs) are preferred for standardization and optimized staining, cytological smears are an alternative when CBs are unavailable. However, the literature on ICC protocols for smears is sparse. This review addresses preparation, fixation and protocols for nuclear and cytoplasmic antibodies on smears, drawing from our laboratory's experience.

Methods

We reviewed procedures for ICC on cytological smears using existing literature and practical insights from our laboratory.

Results

Commercially available antibodies were found to be reliable for ICC on smears if specimens are properly prepared and fixed. Protocols developed in our laboratory maintained antigenicity and provided clear staining results.

Conclusions

Although ICC on CBs is the gold standard for standardization, cytological smears are a viable alternative when CBs are unavailable. Success in ICC on smears depends on proper preparation and fixation. This review offers practical protocols and insights to help laboratories optimize ICC on cytological smears. Further research and standardization are necessary to enhance reproducibility and reliability of ICC on smears. The practical information provided is based on personal experience in our laboratory.

目的:免疫细胞化学(ICC)对于提高诊断准确性以及确定诊断、预后和靶向治疗的标志物至关重要。虽然细胞块(CB)是标准化和优化染色的首选,但在没有 CB 的情况下,细胞涂片也是一种替代方法。然而,有关涂片的 ICC 方案的文献却很少。本综述根据我们实验室的经验,探讨了涂片上核抗体和细胞质抗体的制备、固定和方案:方法:我们利用现有文献和本实验室的实践经验对细胞涂片上的 ICC 程序进行了回顾:结果:我们发现,如果标本准备和固定得当,市场上出售的抗体对涂片上的 ICC 是可靠的。我们实验室制定的方案保持了抗原性并提供了清晰的染色结果:尽管涂片上的 ICC 是标准化的黄金标准,但在没有 CB 时,细胞学涂片也是一种可行的替代方法。涂片 ICC 的成功取决于正确的制备和固定。本综述提供了实用的方案和见解,帮助实验室优化细胞学涂片上的 ICC。为提高涂片 ICC 的可重复性和可靠性,有必要开展进一步的研究和标准化工作。所提供的实用信息均基于我们实验室的个人经验。
{"title":"Practical issues related to immunocytochemistry on cytological smears: Tips and recommendations","authors":"Maria D. Lozano,&nbsp;Allan Argueta,&nbsp;Ramón Robledano,&nbsp;Jaione García,&nbsp;Vanessa Ocon,&nbsp;Nerea Gómez,&nbsp;Nassira Fernandez","doi":"10.1111/cyt.13419","DOIUrl":"10.1111/cyt.13419","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Immunocytochemistry (ICC) is essential for enhancing diagnostic accuracy and identifying markers for diagnosis, prognosis and targeted therapies. While cell blocks (CBs) are preferred for standardization and optimized staining, cytological smears are an alternative when CBs are unavailable. However, the literature on ICC protocols for smears is sparse. This review addresses preparation, fixation and protocols for nuclear and cytoplasmic antibodies on smears, drawing from our laboratory's experience.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We reviewed procedures for ICC on cytological smears using existing literature and practical insights from our laboratory.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Commercially available antibodies were found to be reliable for ICC on smears if specimens are properly prepared and fixed. Protocols developed in our laboratory maintained antigenicity and provided clear staining results.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Although ICC on CBs is the gold standard for standardization, cytological smears are a viable alternative when CBs are unavailable. Success in ICC on smears depends on proper preparation and fixation. This review offers practical protocols and insights to help laboratories optimize ICC on cytological smears. Further research and standardization are necessary to enhance reproducibility and reliability of ICC on smears. The practical information provided is based on personal experience in our laboratory.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55187,"journal":{"name":"Cytopathology","volume":"35 6","pages":"761-769"},"PeriodicalIF":1.2,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cyt.13419","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141621848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Oncocytic/Hürthle cell lesions have the same implied risk of neoplasm/malignancy as their follicular counterparts 肿瘤细胞/Hürthle 细胞病变与滤泡性病变具有相同的肿瘤/恶性肿瘤隐含风险。
IF 1.2 4区 医学 Q4 CELL BIOLOGY Pub Date : 2024-07-16 DOI: 10.1111/cyt.13424
Diana Lin, C. Alexandra Hanna, Andra Frost, Allison Wrenn, Isam Eltoum

Introduction

There are conflicting results on whether the presence of oncocytes modifies the risk of neoplasm (RON) or malignancy (ROM) for thyroid fine-needle aspirates (FNAs): Atypia of undetermined significance AUS and Follicular Neoplasm, FN, or Oncocytic Neoplasm, ON. To our knowledge, the effect of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) has not yet been studied. We compared RON and ROM between follicular type AUS (AUS-FT) and oncocytic type AUS (AUS-OT) and between FN and ON.

Materials and Methods

We retrospectively analysed all thyroid FNAs with the diagnostic category of AUS-other or Neoplasm (2005–2015). AUS-FT had predominance of microfollicles and AUS-OT had predominance of oncocytes. Histology follow-up was then reviewed and RON, ROM was then calculated and compared (significant at p < 0.05). We repeated the search for 2018 to evaluate for NIFTP effect.

Results

Pre-NIFTP, 859/5063 cases (17%) were AUS-FT, AUS-OT, FN, and ON. Histology follow-up was available for 297 cases (35%). RON was 83/183 (45%) for AUS-FT, 35/76 (46%) for AUS-OT, 15/25 (60%) for FN and 11/13 (85%) for ON. Post-NIFTP, RON was 11/31 (35%) for AUS-FT, 5/8 (63%) for AUS-OT, 1/2 (50%) for FN and 4/5 (80%) for ON. For both periods, RON, ROM of AUS-FT was not significantly different than AUS-OT, and no significant differences were observed comparing FN and ON.

Conclusion

The predominance of oncocytes does not modify the implied RON, ROM for categories of AUS or FNON, even after the adoption of NIFTP.

导言:关于癌细胞的存在是否会改变甲状腺细针穿刺(FNA)的肿瘤(RON)或恶性(ROM)风险,目前尚存在相互矛盾的结果:意义未定的不典型性(AUS)和滤泡性肿瘤(FN)或肿瘤细胞性肿瘤(ON)。据我们所知,目前尚未研究过具有乳头状核特征的非侵袭性甲状腺滤泡性肿瘤(NIFTP)的影响。我们比较了滤泡型甲状腺瘤(AUS-FT)和肿瘤细胞型甲状腺瘤(AUS-OT)之间以及FN和ON之间的RON和ROM:我们对所有诊断类别为AUS-其他或肿瘤(2005-2015年)的甲状腺FNA进行了回顾性分析。AUS-FT以微滤泡为主,AUS-OT以肿瘤细胞为主。然后对组织学随访进行复查,计算并比较 RON、ROM(以 p 为显著结果):NIFTP前,859/5063例(17%)为AUS-FT、AUS-OT、FN和ON。297例(35%)获得了组织学随访。AUS-FT的RON为83/183(45%),AUS-OT为35/76(46%),FN为15/25(60%),ON为11/13(85%)。NIFTP 后,RON 在 AUS-FT 为 11/31(35%),AUS-OT 为 5/8(63%),FN 为 1/2 (50%),ON 为 4/5(80%)。在这两个时期,AUS-FT的RON、ROM与AUS-OT没有明显差异,FN和ON也没有明显差异:结论:即使在采用 NIFTP 后,肿瘤细胞的优势也不会改变 AUS 或 FNON 类别的隐含 RON、ROM。
{"title":"Oncocytic/Hürthle cell lesions have the same implied risk of neoplasm/malignancy as their follicular counterparts","authors":"Diana Lin,&nbsp;C. Alexandra Hanna,&nbsp;Andra Frost,&nbsp;Allison Wrenn,&nbsp;Isam Eltoum","doi":"10.1111/cyt.13424","DOIUrl":"10.1111/cyt.13424","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>There are conflicting results on whether the presence of oncocytes modifies the risk of neoplasm (RON) or malignancy (ROM) for thyroid fine-needle aspirates (FNAs): Atypia of undetermined significance AUS and Follicular Neoplasm, FN, or Oncocytic Neoplasm, ON. To our knowledge, the effect of non-invasive follicular thyroid neoplasm with papillary-like nuclear features (NIFTP) has not yet been studied. We compared RON and ROM between follicular type AUS (AUS-FT) and oncocytic type AUS (AUS-OT) and between FN and ON.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Materials and Methods</h3>\u0000 \u0000 <p>We retrospectively analysed all thyroid FNAs with the diagnostic category of AUS-other or Neoplasm (2005–2015). AUS-FT had predominance of microfollicles and AUS-OT had predominance of oncocytes. Histology follow-up was then reviewed and RON, ROM was then calculated and compared (significant at <i>p</i> &lt; 0.05). We repeated the search for 2018 to evaluate for NIFTP effect.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Pre-NIFTP, 859/5063 cases (17%) were AUS-FT, AUS-OT, FN, and ON. Histology follow-up was available for 297 cases (35%). RON was 83/183 (45%) for AUS-FT, 35/76 (46%) for AUS-OT, 15/25 (60%) for FN and 11/13 (85%) for ON. Post-NIFTP, RON was 11/31 (35%) for AUS-FT, 5/8 (63%) for AUS-OT, 1/2 (50%) for FN and 4/5 (80%) for ON. For both periods, RON, ROM of AUS-FT was not significantly different than AUS-OT, and no significant differences were observed comparing FN and ON.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>The predominance of oncocytes does not modify the implied RON, ROM for categories of AUS or FNON, even after the adoption of NIFTP.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55187,"journal":{"name":"Cytopathology","volume":"35 6","pages":"733-737"},"PeriodicalIF":1.2,"publicationDate":"2024-07-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/cyt.13424","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141621847","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Accuracy of ultrasound-guided fine-needle aspiration cytology in evaluation of thyroid nodules using different ultrasonographic and cytological features 超声引导下细针穿刺细胞学利用不同的超声和细胞学特征评估甲状腺结节的准确性。
IF 1.2 4区 医学 Q4 CELL BIOLOGY Pub Date : 2024-07-13 DOI: 10.1111/cyt.13420
Fayed Al-Yousofy, Mukhtar Hamood, Abdullah M. Almatary, Abdullatif Mothanna, Saleh Al-Wageeh, Saeed T. Nasher, Ammar Alselwi, Huda Hassan, Anwer Al-Yousofy, Radwan H. Ahmad

Background

Fine-needle aspiration cytology (FNAC) is a reliable method for preoperative evaluation of thyroid nodules particularly if ultrasound-guided (USG-FNAC). The main purpose of this study is to evaluate the efficacy of USG-FNAC and its accuracy.

Methods

We retrospectively studied 212 thyroidectomy cases with preoperative ultrasonography and FNAC data during the period 2015–2022 using TI-RADS for final ultrasound diagnosis and Bethesda system for cytological diagnosis.

Results

The studied cases were 200 females and 12 males. Thyroid cancer was more prevalent under 20 years old (78.5%). Papillary thyroid carcinoma comprises 84% of all cancer cases. Significant ultrasound features (p-value <0.05) favour malignancy were hypoechogenicity (66%), mixed echogenicity (84%), irregular border (61%), microcalcification (68%) and rim halo (63.6%). Malignancy was found in 21% of TI-RADS-2, 65% of TI-RADS-4 and 100% of TI-RADS-5. There is a significant difference between different categories of Bethesda system. All cases in Cat-VI were malignant (100%). Malignancy was also found in 81% of Cat-V, 20% of Cat-IV, 33% of Cat-III, 16% of Cat-II and 43% of Cat-I. Cytological features consistent with malignancy were as follows: grooving (94%), nuclear irregularities (89%), nuclear pseudoinclusion (89%) and little colloid (82%). In our study, USG-FNAC sensitivity was 83%, specificity 85%, PPV 85%, NPV 83% and accuracy 84%.

Conclusion

Ultrasound features in favour of malignancy in thyroid nodules are hypoechoic or complex echogenicity, irregular border, punctuate calcification and presence of rim halo. Cytological features in favour of malignancy are grooving, nuclear irregularities, nuclear pseudoinclusion and little or absent colloid.

背景:细针穿刺细胞学检查(FNAC)是甲状腺结节术前评估的可靠方法,尤其是在超声引导下(USG-FNAC)。本研究的主要目的是评估 USG-FNAC 的疗效及其准确性:我们回顾性研究了 2015-2022 年间 212 例甲状腺切除术病例的术前超声和 FNAC 数据,使用 TI-RADS 进行最终超声诊断,使用 Bethesda 系统进行细胞学诊断:研究病例中有 200 名女性和 12 名男性。甲状腺癌的发病年龄多在 20 岁以下(78.5%)。甲状腺乳头状癌占所有癌症病例的 84%。重要的超声特征(P值 结论:有利于甲状腺结节恶性的超声特征是低回声或复合回声、边界不规则、点状钙化和边缘光环。有利于恶性的细胞学特征是沟纹、核不规则、核假包涵、胶体少或无。
{"title":"Accuracy of ultrasound-guided fine-needle aspiration cytology in evaluation of thyroid nodules using different ultrasonographic and cytological features","authors":"Fayed Al-Yousofy,&nbsp;Mukhtar Hamood,&nbsp;Abdullah M. Almatary,&nbsp;Abdullatif Mothanna,&nbsp;Saleh Al-Wageeh,&nbsp;Saeed T. Nasher,&nbsp;Ammar Alselwi,&nbsp;Huda Hassan,&nbsp;Anwer Al-Yousofy,&nbsp;Radwan H. Ahmad","doi":"10.1111/cyt.13420","DOIUrl":"10.1111/cyt.13420","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Fine-needle aspiration cytology (FNAC) is a reliable method for preoperative evaluation of thyroid nodules particularly if ultrasound-guided (USG-FNAC). The main purpose of this study is to evaluate the efficacy of USG-FNAC and its accuracy.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We retrospectively studied 212 thyroidectomy cases with preoperative ultrasonography and FNAC data during the period 2015–2022 using TI-RADS for final ultrasound diagnosis and Bethesda system for cytological diagnosis.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>The studied cases were 200 females and 12 males. Thyroid cancer was more prevalent under 20 years old (78.5%). Papillary thyroid carcinoma comprises 84% of all cancer cases. Significant ultrasound features (<i>p</i>-value &lt;0.05) favour malignancy were hypoechogenicity (66%), mixed echogenicity (84%), irregular border (61%), microcalcification (68%) and rim halo (63.6%). Malignancy was found in 21% of TI-RADS-2, 65% of TI-RADS-4 and 100% of TI-RADS-5. There is a significant difference between different categories of Bethesda system. All cases in Cat-VI were malignant (100%). Malignancy was also found in 81% of Cat-V, 20% of Cat-IV, 33% of Cat-III, 16% of Cat-II and 43% of Cat-I. Cytological features consistent with malignancy were as follows: grooving (94%), nuclear irregularities (89%), nuclear pseudoinclusion (89%) and little colloid (82%). In our study, USG-FNAC sensitivity was 83%, specificity 85%, PPV 85%, NPV 83% and accuracy 84%.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Ultrasound features in favour of malignancy in thyroid nodules are hypoechoic or complex echogenicity, irregular border, punctuate calcification and presence of rim halo. Cytological features in favour of malignancy are grooving, nuclear irregularities, nuclear pseudoinclusion and little or absent colloid.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55187,"journal":{"name":"Cytopathology","volume":"35 6","pages":"738-748"},"PeriodicalIF":1.2,"publicationDate":"2024-07-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141602206","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cytomorphological characteristics of low-grade papillary urothelial carcinoma in voided urine samples: Distinction from benign and high-grade papillary urothelial carcinoma 排空尿液样本中低级别乳头状尿路上皮癌的细胞形态学特征:与良性和高级别乳头状尿路上皮癌的区别。
IF 1.2 4区 医学 Q4 CELL BIOLOGY Pub Date : 2024-07-11 DOI: 10.1111/cyt.13413
Kotaro Takeda, Adebowale J. Adeniran, Angelique W. Levi, Haiming Tang, Guoping Cai

Objective

Given its frequent recurrence and the potential for high-grade transformation, accurate diagnosis of low-grade papillary urothelial carcinoma (LGPUC) in urine cytology is clinically important. We attempted to identify cytomorphologic features in urine samples, which could be helpful for the identification of LGPUC.

Methods

We conducted a retrospective review of voided urine specimens collected from patients with histopathologic diagnoses of LGPUC. Their cytomorphological features were compared with those from patients with benign conditions and high-grade papillary urothelial carcinoma (HGPUC).

Results

A total of 115 voided urine specimens were evaluated, including 30 benign, 41 LGPUC, and 44 HGPUC cases. In LGPUC, 18 cases (44%) were diagnosed as atypical, a proportion significantly higher than that observed in benign cases (4 cases, 13%), while the remaining 23 cases (56%) were diagnosed as negative. LGPUC urine samples tended to have higher cellularity than benign cases, but the difference was not statistically significant. Three cytological features, namely nuclear enlargement, higher nuclear-to-cytoplasmic (N/C) ratio, and presence of small cell clusters, were statistically more prevalent in LGPUC compared to benign cases, although the changes were relatively subtle. In contrast, cytomorphological distinction between LGPUC and HGPUC was evident, as high cellularity, nuclear enlargement, hyperchromasia, high N/C ratio, irregular nuclear membrane, and apoptosis were significantly more prevalent in HGPUC cases.

Conclusions

Several cytomorphologic features in voided urine samples were more prevalent in cases with LGPUC, albeit not observed in all instances. Since these alterations were relatively subtle, meticulous attention to these cytomorphologic details is crucial to suggest the possibility of LGPUC.

目的:鉴于低级别乳头状尿路上皮癌(LGPUC)经常复发并可能发生高级别转化,因此在尿液细胞学中准确诊断低级别乳头状尿路上皮癌(LGPUC)具有重要的临床意义。我们试图确定尿液样本中的细胞形态学特征,这可能有助于鉴别 LGPUC:我们对组织病理学诊断为 LGPUC 患者的排空尿液标本进行了回顾性研究。方法:我们对组织病理学诊断为 LGPUC 患者的排空尿液标本进行了回顾性研究,并将其细胞形态学特征与良性病变和高级别乳头状尿路上皮癌(HGPUC)患者的细胞形态学特征进行了比较:结果:共评估了 115 份排尿标本,包括 30 例良性病例、41 例 LGPUC 和 44 例 HGPUC。在 LGPUC 中,18 例(44%)被诊断为非典型,这一比例明显高于良性病例(4 例,13%),而其余 23 例(56%)被诊断为阴性。与良性病例相比,LGPUC 尿液样本的细胞率较高,但差异无统计学意义。与良性病例相比,LGPUC 的三个细胞学特征,即核增大、核与细胞质(N/C)比值升高和出现小细胞团,在统计学上更为普遍,尽管这些变化相对细微。相比之下,LGPUC和HGPUC的细胞形态学区别很明显,因为高细胞度、核增大、高色素沉着、高N/C比值、不规则核膜和细胞凋亡在HGPUC病例中明显更普遍:结论:尽管并非在所有情况下都能观察到LGPUC病例,但排空尿液样本中的一些细胞形态学特征在LGPUC病例中更为普遍。由于这些改变相对微妙,因此仔细观察这些细胞形态学细节对提示 LGPUC 的可能性至关重要。
{"title":"Cytomorphological characteristics of low-grade papillary urothelial carcinoma in voided urine samples: Distinction from benign and high-grade papillary urothelial carcinoma","authors":"Kotaro Takeda,&nbsp;Adebowale J. Adeniran,&nbsp;Angelique W. Levi,&nbsp;Haiming Tang,&nbsp;Guoping Cai","doi":"10.1111/cyt.13413","DOIUrl":"10.1111/cyt.13413","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>Given its frequent recurrence and the potential for high-grade transformation, accurate diagnosis of low-grade papillary urothelial carcinoma (LGPUC) in urine cytology is clinically important. We attempted to identify cytomorphologic features in urine samples, which could be helpful for the identification of LGPUC.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We conducted a retrospective review of voided urine specimens collected from patients with histopathologic diagnoses of LGPUC. Their cytomorphological features were compared with those from patients with benign conditions and high-grade papillary urothelial carcinoma (HGPUC).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>A total of 115 voided urine specimens were evaluated, including 30 benign, 41 LGPUC, and 44 HGPUC cases. In LGPUC, 18 cases (44%) were diagnosed as atypical, a proportion significantly higher than that observed in benign cases (4 cases, 13%), while the remaining 23 cases (56%) were diagnosed as negative. LGPUC urine samples tended to have higher cellularity than benign cases, but the difference was not statistically significant. Three cytological features, namely nuclear enlargement, higher nuclear-to-cytoplasmic (N/C) ratio, and presence of small cell clusters, were statistically more prevalent in LGPUC compared to benign cases, although the changes were relatively subtle. In contrast, cytomorphological distinction between LGPUC and HGPUC was evident, as high cellularity, nuclear enlargement, hyperchromasia, high N/C ratio, irregular nuclear membrane, and apoptosis were significantly more prevalent in HGPUC cases.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Several cytomorphologic features in voided urine samples were more prevalent in cases with LGPUC, albeit not observed in all instances. Since these alterations were relatively subtle, meticulous attention to these cytomorphologic details is crucial to suggest the possibility of LGPUC.</p>\u0000 </section>\u0000 </div>","PeriodicalId":55187,"journal":{"name":"Cytopathology","volume":"35 6","pages":"724-732"},"PeriodicalIF":1.2,"publicationDate":"2024-07-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141592223","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Cytopathology
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1